October 01, 2014 1:40 PM ET

Pharmaceuticals

Company Overview of Colby Pharmaceutical Company

Key Executives for Colby Pharmaceutical Company

NameBoard RelationshipsTitleAge
David A. Zarling Ph.D., MBA9 RelationshipsChief Executive Officer and Director--
Minesh P. Mehta M.D., MBChB28 RelationshipsChief Medical Officer56
Anne K. Vallerga MA Ph.D.6 RelationshipsVice President and Director--
Hirak Basu Ph.D.No RelationshipsChief Scientific Officer--

Colby Pharmaceutical Company Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kenneth W. Narducy Ph.D., MBA 10 RelationshipsSt. Charles Pharmaceuticals, Inc.--
David A. Zarling Ph.D., MBA 9 RelationshipsPangene Corporation--
Anne K. Vallerga MA Ph.D. 6 RelationshipsColby Pharmaceutical Company--
Richard N. Zare Ph.D. 28 RelationshipsFluidigm Corporation--
George Wilding M.D. 6 RelationshipsColby Pharmaceutical Company--
View All Board Members

Colby Pharmaceutical Company Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D.George Wilding6 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
428.7K
Bonus
549.1K
Total Short Term Compensation
627.7K
Total Value of Options
17.4M
Compensation as of Fiscal Year
Colby Pharmaceutical Company CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Ryan Continues European Expansion with Opening of New Office in Paris, France; Jean-Paul Ouaksel Hires as Principal to Lead French Practice
September 29, 2014 2:30 PM ET
Hindustan Unilever Limited Announces Key Changes in the Management Committee, Effective November 2014
September 26, 2014 10:30 AM ET
P&G Vice Chairman and Special Advisor to the Chairman and Chief Executive Officer Werner Geissler to Retire
September 24, 2014 1:30 PM ET
The Clorox Company Announces Executive Changes
September 23, 2014 12:30 PM ET
The Clorox Company Announces Executive Changes, Effective November 20, 2014
September 23, 2014 11:57 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Colby Pharmaceutical Company, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.